Charles Schwab’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $89.1M | Sell |
613,358
-12,248
| -2% | -$1.52M | 0.01% | 854 |
|
|
2026
Q1 | $66.4M | Sell |
625,606
-6,844
| -1% | -$778K | 0.01% | 969 |
|
|
2025
Q4 | $67.2M | Sell |
632,450
-2,699
| -0.4% | -$272K | 0.01% | 958 |
|
|
2025
Q3 | $59.5M | Sell |
635,149
-2,372
| -0.4% | -$221K | 0.01% | 1042 |
|
|
2025
Q2 | $55.3M | Sell |
637,521
-3,898
| -0.6% | -$326K | 0.01% | 1043 |
|
|
2025
Q1 | $49.5M | Sell |
641,419
-17,456
| -3% | -$1.6M | 0.01% | 1078 |
|
|
2024
Q4 | $63.7M | Buy |
658,875
+14,708
| +2% | +$1.48M | 0.01% | 954 |
|
|
2024
Q3 | $61M | Buy |
644,167
+428
| +0.1% | +$37.4K | 0.01% | 973 |
|
|
2024
Q2 | $53.7M | Buy |
643,739
+40,372
| +7% | +$3.36M | 0.01% | 1023 |
|
|
2024
Q1 | $51.8M | Buy |
603,367
+7,553
| +1% | +$615K | 0.01% | 1023 |
|
|
2023
Q4 | $49.2M | Sell |
595,814
-1,683
| -0.3% | -$124K | 0.01% | 990 |
|
|
2023
Q3 | $43M | Buy |
597,497
+7,089
| +1% | +$538K | 0.01% | 984 |
|
|
2023
Q2 | $44.7M | Sell |
590,408
-16,058
| -3% | -$1.08M | 0.01% | 922 |
|
|
2023
Q1 | $38.3M | Sell |
606,466
-6,666
| -1% | -$391K | 0.01% | 1011 |
|
|
2022
Q4 | $33.3M | Buy |
613,132
+866
| +0.1% | +$51.4K | 0.01% | 1082 |
|
|
2022
Q3 | $35M | Buy |
612,266
+581
| +0.1% | +$32.2K | 0.01% | 989 |
|
|
2022
Q2 | $28.4M | Buy |
611,685
+27,447
| +5% | +$1.44M | 0.01% | 1135 |
|
|
2022
Q1 | $33.4M | Buy |
584,238
+37,742
| +7% | +$1.95M | 0.01% | 1154 |
|
|
2021
Q4 | $28.8M | Buy |
546,496
+21,842
| +4% | +$1.17M | 0.01% | 1295 |
|
|
2021
Q3 | $26.3M | Buy |
524,654
+19,669
| +4% | +$1.02M | 0.01% | 1346 |
|
|
2021
Q2 | $29.7M | Buy |
504,985
+5,549
| +1% | +$343K | 0.01% | 1256 |
|
|
2021
Q1 | $32.5M | Sell |
499,436
-4,545
| -0.9% | -$279K | 0.01% | 1131 |
|
|
2020
Q4 | $27.7M | Sell |
503,981
-17,342
| -3% | -$885K | 0.01% | 1167 |
|
|
2020
Q3 | $23M | Sell |
521,323
-46,683
| -8% | -$2.05M | 0.01% | 1111 |
|
|
2020
Q2 | $24M | Sell |
568,006
-77,416
| -12% | -$2.98M | 0.01% | 1044 |
|
|
2020
Q1 | $25.6M | Buy |
645,422
+18,577
| +3% | +$785K | 0.02% | 841 |
|
|
2019
Q4 | $27.9M | Buy |
626,845
+13,705
| +2% | +$527K | 0.02% | 982 |
|
|
2019
Q3 | $21M | Buy |
613,140
+31,818
| +5% | +$1.1M | 0.01% | 1119 |
|
|
2019
Q2 | $21.9M | Buy |
581,322
+97,663
| +20% | +$3.34M | 0.01% | 1073 |
|
|
2019
Q1 | $14.8M | Buy |
483,659
+250,498
| +107% | +$7.65M | 0.01% | 1320 |
|
|
2018
Q4 | $6.46M | Buy |
+233,161
| New | +$6.41M | ﹤0.01% | 1746 |
|
Other funds holding ACA
NAMI
RA
Charles Schwab's ACA Position: Q2 2026 in Review
Charles Schwab reduced its Arcosa (ACA) stake by 2% in Q2 2026, selling an estimated $1.52M and leaving 613,358 shares worth $89.1M. The position accounts for 0.01% of the portfolio, ranked #854.
Charles Schwab first reported a position in ACA in Q4 2018 and has held it in 31 quarters since. 426 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- Charles Schwab held 613,358 shares of Arcosa worth $89.1M as of Q2 2026.
- Charles Schwab sold 12,248 Arcosa shares in Q2 2026, an estimated $1.52M.
- Arcosa made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #854 holding.
- Charles Schwab first reported a position in Arcosa in Q4 2018 and has held it in 31 quarters since.
- 426 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.